232 related articles for article (PubMed ID: 21534039)
41. Synthesis and evaluation of novel podophyllotoxin analogs.
Li J; Hua HM; Tang YB; Zhang S; Ohkoshi E; Lee KH; Xiao Zy
Bioorg Med Chem Lett; 2012 Jul; 22(13):4293-5. PubMed ID: 22658864
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological evaluation of 4β-acrylamidopodophyllotoxin congeners as DNA damaging agents.
Kamal A; Suresh P; Janaki Ramaiah M; Mallareddy A; Kumar BA; Raju P; Vinay Gopal J; Pushpavalli SN; Lavanya A; Sarma P; Pal-Bhadra M
Bioorg Med Chem; 2011 Aug; 19(15):4589-600. PubMed ID: 21737288
[TBL] [Abstract][Full Text] [Related]
43. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation.
Han HW; Lin HY; He DL; Ren Y; Sun WX; Liang L; Du MH; Li DC; Chu YC; Yang MK; Wang XM; Yang YH
Chem Biodivers; 2018 Nov; 15(11):e1800289. PubMed ID: 30194898
[TBL] [Abstract][Full Text] [Related]
44. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of new 4β-anilino-4'-O-demethyl-4-desoxypodophyllotoxin derivatives as potential antitumor agents.
Wang L; Yang F; Yang X; Guan X; Hu C; Liu T; He Q; Yang B; Hu Y
Eur J Med Chem; 2011 Jan; 46(1):285-96. PubMed ID: 21145139
[TBL] [Abstract][Full Text] [Related]
46. [Synthesis and antitumor activity of novel indole podophyllotoxin derivatives].
Tian DL; Liang CP; Liang J; Chen H
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2532-2537. PubMed ID: 31359720
[TBL] [Abstract][Full Text] [Related]
47. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
48. In-vitro antitumor activity evaluation of hyperforin derivatives.
Sun F; Liu JY; He F; Liu Z; Wang R; Wang DM; Wang YF; Yang DP
J Asian Nat Prod Res; 2011 Aug; 13(8):688-99. PubMed ID: 21751836
[TBL] [Abstract][Full Text] [Related]
49. Semi-synthesis and biological evaluation of 1,2,3-triazole-based podophyllotoxin congeners as potent antitumor agents inducing apoptosis in HepG2 cells.
Chen J; Ma L; Zhang R; Tang J; Lai H; Wang J; Wang G; Xu Q; Chen T; Peng F; Qiu J; Liang X; Cao D; Ran Y; Peng A; Wei Y; Chen L
Arch Pharm (Weinheim); 2012 Dec; 345(12):945-56. PubMed ID: 22949330
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of novel derivatives of bispodophyllotoxin as potential antineoplastic agents--part XVI.
Liu YQ; Liu YQ; Tian X; Yang L
Nat Prod Res; 2008 Mar; 22(4):285-91. PubMed ID: 18322843
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and cytotoxic evaluation of C-9 oxidized podophyllotoxin derivatives.
Castro MA; Miguel del Corral JM; Gordaliza M; García PA; Gómez-Zurita MA; San Feliciano A
Bioorg Med Chem; 2007 Feb; 15(4):1670-8. PubMed ID: 17197187
[TBL] [Abstract][Full Text] [Related]
52. Reengineered epipodophyllotoxin.
Magedov IV; Evdokimov NM; Karki M; Peretti AS; Lima DT; Frolova LV; Reisenauer MR; Romero AE; Tongwa P; Fonari A; Altig J; Rogelj S; Antipin MY; Shuster CB; Kornienko A
Chem Commun (Camb); 2012 Oct; 48(84):10416-8. PubMed ID: 22986348
[TBL] [Abstract][Full Text] [Related]
53. [Synthesis and antitumor activity of 4-alkylthio-4-deoxy-4'-demethylepipodophyllotxin derivatives].
Wang ZG; Ma WY; Li BS; Zhang CN
Yao Xue Xue Bao; 1992; 27(9):656-61. PubMed ID: 1293935
[TBL] [Abstract][Full Text] [Related]
54. Substituted ajoenes as novel anti-cancer agents.
Hunter R; Kaschula CH; Parker IM; Caira MR; Richards P; Travis S; Taute F; Qwebani T
Bioorg Med Chem Lett; 2008 Oct; 18(19):5277-9. PubMed ID: 18774712
[TBL] [Abstract][Full Text] [Related]
55. Cytotoxicity, apoptosis induction, and mitotic arrest by a novel podophyllotoxin glucoside, 4DPG, in tumor cells.
Qi YL; Liao F; Zhao CQ; Lin YD; Zuo MX
Acta Pharmacol Sin; 2005 Aug; 26(8):1000-8. PubMed ID: 16038635
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological evaluation of new selective cytotoxic cyclolignans derived from podophyllotoxin.
Castro MA; Miguel del Corral JM; Gordaliza M; García PA; Gómez-Zurita MA; García-Grávalos MD; de la Iglesia-Vicente J; Gajate C; An F; Mollinedo F; San Feliciano A
J Med Chem; 2004 Feb; 47(5):1214-22. PubMed ID: 14971901
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and antitumor activity evaluation of a novel series of camptothecin analogs.
Lv J; Guo N; Wen SP; Teng YO; Ma MX; Yu P
J Asian Nat Prod Res; 2013; 15(8):867-74. PubMed ID: 23796391
[TBL] [Abstract][Full Text] [Related]
58. Alkyl and carboxylalkyl esters of 4'-demethyl-4-deoxypodophyllotoxin: synthesis, cytotoxic, and antitumor activity.
You YJ; Kim Y; Nam NH; Bang SC; Ahn BZ
Eur J Med Chem; 2004 Feb; 39(2):189-93. PubMed ID: 14987827
[TBL] [Abstract][Full Text] [Related]
59. Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells.
Anyanwutaku IO; Guo X; Chen HX; Ji Z; Lee KH; Cheng YC
Mol Pharmacol; 1996 Apr; 49(4):721-6. PubMed ID: 8609902
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological study of a new series of 4'-demethylepipodophyllotoxin derivatives.
Duca M; Guianvarc'h D; Meresse P; Bertounesque E; Dauzonne D; Kraus-Berthier L; Thirot S; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C
J Med Chem; 2005 Jan; 48(2):593-603. PubMed ID: 15658872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
